Drug Type Chemical drugs |
Synonyms CRD 4730, CRD4730 |
Target |
Mechanism CaMKII inhibitors(Calcium/Calmodulin dependent protein kinase II inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Defects, Congenital | Phase 2 | US | 07 Nov 2023 | |
Heart Defects, Congenital | Phase 2 | CA | 07 Nov 2023 | |
Heart Defects, Congenital | Phase 2 | FR | 07 Nov 2023 | |
Heart Defects, Congenital | Phase 2 | IT | 07 Nov 2023 | |
Polymorphic Catecholergic Ventricular Tachycardia | Phase 2 | US | 07 Nov 2023 | |
Polymorphic Catecholergic Ventricular Tachycardia | Phase 2 | CA | 07 Nov 2023 | |
Polymorphic Catecholergic Ventricular Tachycardia | Phase 2 | FR | 07 Nov 2023 | |
Polymorphic Catecholergic Ventricular Tachycardia | Phase 2 | IT | 07 Nov 2023 |